Charles Schwab’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Buy |
161,821
+131,853
| +440% | +$527K | ﹤0.01% | 3039 |
|
|
2025
Q1 | $95.3K | Hold |
29,968
| – | – | ﹤0.01% | 3353 |
|
|
2024
Q4 | $160K | Buy |
29,968
+14,300
| +91% | +$76.5K | ﹤0.01% | 3351 |
|
|
2024
Q3 | $82.7K | Hold |
15,668
| – | – | ﹤0.01% | 3387 |
|
|
2024
Q2 | $28.5K | Hold |
15,668
| – | – | ﹤0.01% | 3566 |
|
|
2024
Q1 | $27.9K | Hold |
15,668
| – | – | ﹤0.01% | 3418 |
|
|
2023
Q4 | $27.6K | Hold |
15,668
| – | – | ﹤0.01% | 3456 |
|
|
2023
Q3 | $22.9K | Hold |
15,668
| – | – | ﹤0.01% | 3500 |
|
|
2023
Q2 | $35.9K | Buy |
+15,668
| New | +$35.9K | ﹤0.01% | 3470 |
|
|
2022
Q1 | – | Sell |
-11,217
| Closed | -$28K | – | 3591 |
|
|
2021
Q4 | $28K | Hold |
11,217
| – | – | ﹤0.01% | 3555 |
|
|
2021
Q3 | $55K | Buy |
+11,217
| New | +$55K | ﹤0.01% | 3440 |
|
|
2021
Q2 | – | Sell |
-13,830
| Closed | -$43K | – | 3438 |
|
|
2021
Q1 | $43K | Buy |
+13,830
| New | +$43K | ﹤0.01% | 3450 |
|
|
2019
Q2 | – | Sell |
-36,275
| Closed | -$146K | – | 3229 |
|
|
2019
Q1 | $146K | Buy |
36,275
+10,375
| +40% | +$41.8K | ﹤0.01% | 3062 |
|
|
2018
Q4 | $96K | Hold |
25,900
| – | – | ﹤0.01% | 3093 |
|
|
2018
Q3 | $223K | Hold |
25,900
| – | – | ﹤0.01% | 3062 |
|
|
2018
Q2 | $285K | Buy |
25,900
+8,400
| +48% | +$92.4K | ﹤0.01% | 2991 |
|
|
2018
Q1 | $202K | Hold |
17,500
| – | – | ﹤0.01% | 2990 |
|
|
2017
Q4 | $182K | Hold |
17,500
| – | – | ﹤0.01% | 2993 |
|
|
2017
Q3 | $279K | Hold |
17,500
| – | – | ﹤0.01% | 2902 |
|
|
2017
Q2 | $212K | Buy |
+17,500
| New | +$212K | ﹤0.01% | 3013 |
|